Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Debt (2020 - 2026)

MDxHealth has reported Total Debt over the past 7 years, most recently at $131.3 million for Q1 2026.

  • For Q1 2026, Total Debt changed N/A year-over-year to $131.3 million; the TTM value through Mar 2026 reached $131.3 million, changed N/A, while the annual FY2025 figure was $102.0 million, 144.21% up from the prior year.
  • Total Debt was $131.3 million for Q1 2026 at MDxHealth, up from $102.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $131.3 million in Q1 2026 and bottomed at $41.8 million in Q4 2024.
  • The 5-year median for Total Debt is $63.9 million (2023), against an average of $79.0 million.
  • Year-over-year, Total Debt skyrocketed 845.73% in 2022 and then tumbled 34.64% in 2024.
  • Over 5 years, Total Debt stood at $55.9 million in 2022, then rose by 14.39% to $63.9 million in 2023, then plummeted by 34.64% to $41.8 million in 2024, then skyrocketed by 144.21% to $102.0 million in 2025, then increased by 28.71% to $131.3 million in 2026.
  • The last three reported values for Total Debt were $131.3 million (Q1 2026), $102.0 million (Q4 2025), and $41.8 million (Q4 2024) per Business Quant data.